Editorial: Obesity and cancer: update on etiology, molecular biomarkers and biotargets, clinical strategies, and epidemiology
- PMID: 37645420
- PMCID: PMC10461616
- DOI: 10.3389/fendo.2023.1258994
Editorial: Obesity and cancer: update on etiology, molecular biomarkers and biotargets, clinical strategies, and epidemiology
Keywords: animal models; cancer; epidemiology—analytic (risk factors); global prevalence; obesity.
Conflict of interest statement
Author ES was employed by the company Allysta Pharmaceuticals, Inc. This relationship did not influence in any way the content of the article. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. The authors declared that they were an editorial board member of Frontiers, at the time of submission. This had no impact on the peer review process and the final decision.
Comment on
- Editorial on the Research Topic Obesity and cancer: update on etiology, molecular biomarkers and biotargets, clinical strategies, and epidemiology
References
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
